Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Phytoestrogen-rich Foods Protect Against Cancer
Scientists at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics have studied the correlation between prostate cancer and phytoestrogen in a large population-based case-control study, determining that men who had a high intake of phytoestrogen-rich food, such as beans (which offered the greatest protection), soya products, linseed, sunflower seeds, berries and peanuts, ran a 26 per cent lower risk of developing prostate cancer.
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Research Shows Beneo(TM) Promotes Probiotic Vitality
Results of new study indicate that Beneo(TM) protects the probiotics through both storage and digestion.
- Research Shows Beneo(TM) Promotes Probiotic Vitality
Results of new study indicate that Beneo(TM) protects the probiotics through both storage and digestion.
- Research Shows Beneo(TM) Promotes Probiotic Vitality
Results of new study indicate that Beneo(TM) protects the probiotics through both storage and digestion.
- Research Shows Beneo(TM) Promotes Probiotic Vitality
Results of new study indicate that Beneo(TM) protects the probiotics through both storage and digestion.
- Beneo(TM) shown to increase bone mineral density
Study designed to evaluate whether Beneo(TM) Synergy 1 can increase calcium retention within bones has found that ORAFTI’s patented enriched Beneo(TM) powder has this positive effect.
- Beneo(TM) shown to increase bone mineral density
Study designed to evaluate whether Beneo(TM) Synergy 1 can increase calcium retention within bones has found that ORAFTI’s patented enriched Beneo(TM) powder has this positive effect.
- Beneo(TM) shown to increase bone mineral density
Study designed to evaluate whether Beneo(TM) Synergy 1 can increase calcium retention within bones has found that ORAFTI’s patented enriched Beneo(TM) powder has this positive effect.
- Beneo(TM) shown to increase bone mineral density
Study designed to evaluate whether Beneo(TM) Synergy 1 can increase calcium retention within bones has found that ORAFTI’s patented enriched Beneo(TM) powder has this positive effect.
- Beneo(TM) shown to increase bone mineral density
Study designed to evaluate whether Beneo(TM) Synergy 1 can increase calcium retention within bones has found that ORAFTI’s patented enriched Beneo(TM) powder has this positive effect.
- Study Review Shows CoQ10 and Pine Bark Synergistically Enhance Cardiovascular Health
Assessment published in the February issue of Evidence Based Integrative Medicine observes that patients who supplemented with the pine tree bark extract known as Pycnogenol® and CoQ10 in combination benefited from the collaborative antioxidant effects.
- Study Review Shows CoQ10 and Pine Bark Synergistically Enhance Cardiovascular Health
Assessment published in the February issue of Evidence Based Integrative Medicine observes that patients who supplemented with the pine tree bark extract known as Pycnogenol® and CoQ10 in combination benefited from the collaborative antioxidant effects.
- Study Review Shows CoQ10 and Pine Bark Synergistically Enhance Cardiovascular Health
Assessment published in the February issue of Evidence Based Integrative Medicine observes that patients who supplemented with the pine tree bark extract known as Pycnogenol® and CoQ10 in combination benefited from the collaborative antioxidant effects.
- Study Review Shows CoQ10 and Pine Bark Synergistically Enhance Cardiovascular Health
Assessment published in the February issue of Evidence Based Integrative Medicine observes that patients who supplemented with the pine tree bark extract known as Pycnogenol® and CoQ10 in combination benefited from the collaborative antioxidant effects.
- Study Review Shows CoQ10 and Pine Bark Synergistically Enhance Cardiovascular Health
Assessment published in the February issue of Evidence Based Integrative Medicine observes that patients who supplemented with the pine tree bark extract known as Pycnogenol® and CoQ10 in combination benefited from the collaborative antioxidant effects.
- Study of Cyanotech's BioAstin(R) Natural Astaxanthin Impact on C-Reactive Protein Levels
Double-blind preliminary study by an independent research group, of 15 subjects taking BioAstin and eight subjects taking Placebo found that subjects who took BioAstin for 56 days showed an average decrease in their measured CRP levels of over 20%, compared to no decline for the placebo group.
- Study of Cyanotech's BioAstin(R) Natural Astaxanthin Impact on C-Reactive Protein Levels
Double-blind preliminary study by an independent research group, of 15 subjects taking BioAstin and eight subjects taking Placebo found that subjects who took BioAstin for 56 days showed an average decrease in their measured CRP levels of over 20%, compared to no decline for the placebo group.
- Study of Cyanotech's BioAstin(R) Natural Astaxanthin Impact on C-Reactive Protein Levels
Double-blind preliminary study by an independent research group, of 15 subjects taking BioAstin and eight subjects taking Placebo found that subjects who took BioAstin for 56 days showed an average decrease in their measured CRP levels of over 20%, compared to no decline for the placebo group.
- Study of Cyanotech's BioAstin(R) Natural Astaxanthin Impact on C-Reactive Protein Levels
Double-blind preliminary study by an independent research group, of 15 subjects taking BioAstin and eight subjects taking Placebo found that subjects who took BioAstin for 56 days showed an average decrease in their measured CRP levels of over 20%, compared to no decline for the placebo group.
- Study Indicates Enterolactone Supports Prostate Health
Swedish research indicates high intake of food items rich in phytoestrogens was associated with a decreased risk of prostate cancer, no association between dietary intake of total or individual lignans or isoflavonoids and risk of prostate cancer was observed and serum levels of enterolactone were correlated with a decreased risk of prostate cancer.
- Study Indicates Enterolactone Supports Prostate Health
Swedish research indicates high intake of food items rich in phytoestrogens was associated with a decreased risk of prostate cancer, no association between dietary intake of total or individual lignans or isoflavonoids and risk of prostate cancer was observed and serum levels of enterolactone were correlated with a decreased risk of prostate cancer.
- Study Indicates Enterolactone Supports Prostate Health
Swedish research indicates high intake of food items rich in phytoestrogens was associated with a decreased risk of prostate cancer, no association between dietary intake of total or individual lignans or isoflavonoids and risk of prostate cancer was observed and serum levels of enterolactone were correlated with a decreased risk of prostate cancer.
- Study Indicates Enterolactone Supports Prostate Health
Swedish research indicates high intake of food items rich in phytoestrogens was associated with a decreased risk of prostate cancer, no association between dietary intake of total or individual lignans or isoflavonoids and risk of prostate cancer was observed and serum levels of enterolactone were correlated with a decreased risk of prostate cancer.
- Major WHO Study Concludes Calcium Supplements Can Reduce Complications During Pregnancy
Study published in the March issue of the American Journal of Obstetrics and Gynecology involved Over 8300 women with low dietary calcium (<600 mg/day, about half of that recommended during pregnancy),and results indicate that when subject supplemented with 1.5g of a calcium supplement per day, incidence of preeclamsia was not signficiantly reduced, but other severe complications and severe gestational hypertension were significantly lower.
- Major WHO Study Concludes Calcium Supplements Can Reduce Complications During Pregnancy
Study published in the March issue of the American Journal of Obstetrics and Gynecology involved Over 8300 women with low dietary calcium (<600 mg/day, about half of that recommended during pregnancy),and results indicate that when subject supplemented with 1.5g of a calcium supplement per day, incidence of preeclamsia was not signficiantly reduced, but other severe complications and severe gestational hypertension were significantly lower.
- Major WHO Study Concludes Calcium Supplements Can Reduce Complications During Pregnancy
Study published in the March issue of the American Journal of Obstetrics and Gynecology involved Over 8300 women with low dietary calcium (<600 mg/day, about half of that recommended during pregnancy),and results indicate that when subject supplemented with 1.5g of a calcium supplement per day, incidence of preeclamsia was not signficiantly reduced, but other severe complications and severe gestational hypertension were significantly lower.
- Major WHO Study Concludes Calcium Supplements Can Reduce Complications During Pregnancy
Study published in the March issue of the American Journal of Obstetrics and Gynecology involved Over 8300 women with low dietary calcium (<600 mg/day, about half of that recommended during pregnancy),and results indicate that when subject supplemented with 1.5g of a calcium supplement per day, incidence of preeclamsia was not signficiantly reduced, but other severe complications and severe gestational hypertension were significantly lower.
- Major WHO Study Concludes Calcium Supplements Can Reduce Complications During Pregnancy
Study published in the March issue of the American Journal of Obstetrics and Gynecology involved Over 8300 women with low dietary calcium (<600 mg/day, about half of that recommended during pregnancy),and results indicate that when subject supplemented with 1.5g of a calcium supplement per day, incidence of preeclamsia was not signficiantly reduced, but other severe complications and severe gestational hypertension were significantly lower.
- Major WHO Study Concludes Calcium Supplements Can Reduce Complications During Pregnancy
Study published in the March issue of the American Journal of Obstetrics and Gynecology involved Over 8300 women with low dietary calcium (<600 mg/day, about half of that recommended during pregnancy),and results indicate that when subject supplemented with 1.5g of a calcium supplement per day, incidence of preeclamsia was not signficiantly reduced, but other severe complications and severe gestational hypertension were significantly lower.
- New Studies On B-Vitamins Not the Final Word
Findings from two new studies (HOPE-2 and NORVIT) on vitamins B-6, B-12 and folate supported the conclusions of a vast body of scientific research which shows that these vitamins help lower homocysteine levels, but failed to support the hypothesis that lowering homocysteine levels in persons who already have cardiovascular disease (CVD) will provide protection against a future cardiovascular event.
- New Studies On B-Vitamins Not the Final Word
Findings from two new studies (HOPE-2 and NORVIT) on vitamins B-6, B-12 and folate supported the conclusions of a vast body of scientific research which shows that these vitamins help lower homocysteine levels, but failed to support the hypothesis that lowering homocysteine levels in persons who already have cardiovascular disease (CVD) will provide protection against a future cardiovascular event.
- New Studies On B-Vitamins Not the Final Word
Findings from two new studies (HOPE-2 and NORVIT) on vitamins B-6, B-12 and folate supported the conclusions of a vast body of scientific research which shows that these vitamins help lower homocysteine levels, but failed to support the hypothesis that lowering homocysteine levels in persons who already have cardiovascular disease (CVD) will provide protection against a future cardiovascular event.
- New Studies On B-Vitamins Not the Final Word
Findings from two new studies (HOPE-2 and NORVIT) on vitamins B-6, B-12 and folate supported the conclusions of a vast body of scientific research which shows that these vitamins help lower homocysteine levels, but failed to support the hypothesis that lowering homocysteine levels in persons who already have cardiovascular disease (CVD) will provide protection against a future cardiovascular event.
- New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity
Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis.
- New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity
Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis.
- New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity
Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis.
- New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity
Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis.
- New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity
Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis.
- New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity
Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis.
- UC Davis Study Shows Grape Seed Extract May Be Effective in Reducing Blood Pressure
One month study was done on 24 male and female patients diagnosed with metabolic syndrome indicates that supplementation with new patent-pending grape seed extract developed and made by Polyphenolics correlates with reduced blood pressure and at higher concetrations, a drop in serum oxidized LDL cholesterol levels was observed.
- UC Davis Study Shows Grape Seed Extract May Be Effective in Reducing Blood Pressure
One month study was done on 24 male and female patients diagnosed with metabolic syndrome indicates that supplementation with new patent-pending grape seed extract developed and made by Polyphenolics correlates with reduced blood pressure and at higher concetrations, a drop in serum oxidized LDL cholesterol levels was observed.
- UC Davis Study Shows Grape Seed Extract May Be Effective in Reducing Blood Pressure
One month study was done on 24 male and female patients diagnosed with metabolic syndrome indicates that supplementation with new patent-pending grape seed extract developed and made by Polyphenolics correlates with reduced blood pressure and at higher concetrations, a drop in serum oxidized LDL cholesterol levels was observed.
- UC Davis Study Shows Grape Seed Extract May Be Effective in Reducing Blood Pressure
One month study was done on 24 male and female patients diagnosed with metabolic syndrome indicates that supplementation with new patent-pending grape seed extract developed and made by Polyphenolics correlates with reduced blood pressure and at higher concetrations, a drop in serum oxidized LDL cholesterol levels was observed.
- UC Davis Study Shows Grape Seed Extract May Be Effective in Reducing Blood Pressure
One month study was done on 24 male and female patients diagnosed with metabolic syndrome indicates that supplementation with new patent-pending grape seed extract developed and made by Polyphenolics correlates with reduced blood pressure and at higher concetrations, a drop in serum oxidized LDL cholesterol levels was observed.
- Study Indicates That Relora® Reduces Stress and Anxiety
Randomized, placebo-controlled, parallel-group, clinical study on Relora® and its anti-anxiety properties, involving 40 healthy, overweight, physically active, 25-50 year old women with anxiety, will be presented in a poster session (C690) at the Federation of American Societies for Experimental Biology (FASEB) Conference in San Francisco on Sunday, April 2nd.
- Study Indicates That Relora® Reduces Stress and Anxiety
Randomized, placebo-controlled, parallel-group, clinical study on Relora® and its anti-anxiety properties, involving 40 healthy, overweight, physically active, 25-50 year old women with anxiety, will be presented in a poster session (C690) at the Federation of American Societies for Experimental Biology (FASEB) Conference in San Francisco on Sunday, April 2nd.
- Study Indicates That Relora® Reduces Stress and Anxiety
Randomized, placebo-controlled, parallel-group, clinical study on Relora® and its anti-anxiety properties, involving 40 healthy, overweight, physically active, 25-50 year old women with anxiety, will be presented in a poster session (C690) at the Federation of American Societies for Experimental Biology (FASEB) Conference in San Francisco on Sunday, April 2nd.
- Study Indicates That Relora® Reduces Stress and Anxiety
Randomized, placebo-controlled, parallel-group, clinical study on Relora® and its anti-anxiety properties, involving 40 healthy, overweight, physically active, 25-50 year old women with anxiety, will be presented in a poster session (C690) at the Federation of American Societies for Experimental Biology (FASEB) Conference in San Francisco on Sunday, April 2nd.
- Fish oil may help protect against retinal degenerative diseases
Invited paper published in Trends in Neuroscience reports on the role that omega-3 fatty acids in fish oil play in protecting cells in the retina from degenerative diseases like retinitis pigmentosa and age-related macular degeneration. According to the researchers, DHA is a precursor to neuroprotectin D1 (NPD1), a major neuroprotective compound, and DHA is found to promote protective cell signaling as well as stimulating the production of NPD1.
- Fish oil may help protect against retinal degenerative diseases
Invited paper published in Trends in Neuroscience reports on the role that omega-3 fatty acids in fish oil play in protecting cells in the retina from degenerative diseases like retinitis pigmentosa and age-related macular degeneration. According to the researchers, DHA is a precursor to neuroprotectin D1 (NPD1), a major neuroprotective compound, and DHA is found to promote protective cell signaling as well as stimulating the production of NPD1.
- Fish oil may help protect against retinal degenerative diseases
Invited paper published in Trends in Neuroscience reports on the role that omega-3 fatty acids in fish oil play in protecting cells in the retina from degenerative diseases like retinitis pigmentosa and age-related macular degeneration. According to the researchers, DHA is a precursor to neuroprotectin D1 (NPD1), a major neuroprotective compound, and DHA is found to promote protective cell signaling as well as stimulating the production of NPD1.
- Fish oil may help protect against retinal degenerative diseases
Invited paper published in Trends in Neuroscience reports on the role that omega-3 fatty acids in fish oil play in protecting cells in the retina from degenerative diseases like retinitis pigmentosa and age-related macular degeneration. According to the researchers, DHA is a precursor to neuroprotectin D1 (NPD1), a major neuroprotective compound, and DHA is found to promote protective cell signaling as well as stimulating the production of NPD1.
- Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo
- Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Watsonville, CA (March 6, 2006) Functional and nutritional interventions showed improvements among children in an orphanage in Saltillo, Mexico. At the end of the 5-month program evaluation, 17 of the 20 children, ages 5-14 years, showed measurable improvements.
The interventions were based on the Holistic Approach to NeuroDevelopment and Learning Efficiency program (HANDLE(R)). The 16 functional difficulties included hyperactivity, aggression, impulsivity, emotional lability, reading and math difficulties, and social isolation, among others.
There were three dietary changes: 1) making water the principal beverage, replacing a powder-based sugar drink; 2) ensuring one serving of animal protein per day; and 3) supplementing the children’s diet with ProEFA(TM) Junior [Omega-3-6-9(TM) Junior], an essential fatty acid blend from Nordic Naturals, Inc., Watsonville, CA.
The children were screened and ranked prior to the intervention period, dietary changes were made, and activity programs designed to address their difficulties were implemented by trained caregivers.
The children were then screened and ranked after the 5-month intervention period. Of the 20 children in the program, 17 demonstrated a significant decrease in the amount of interference they experienced from their identified issues. The largest improvement in function was seen in the 2 children with the most significant problems. The 3 children who showed little improvement had very low scores at baseline.
Healthcare professionals interested in more detail may email Marlene@GetAbleTherapy.com. For information about HANDLE go to www.handle.org.
Founded by husband-and-wife team Joar and Michele Opheim, Nordic Naturals is the leader in omega-3 fish oils and EFA blends with exceptional taste, freshness, and purity levels. The company offers over 50 different fish oil products and EFA blends, including liquids, capsules, and children's chewables. For more information, please visit www.nordicnaturals.com or call 800.662.2544.
###
Shari Hindman /Integral Marketing
303.499.9665
sharilhindman1@comcast.net
|